CCS Dyslipidemia 2021 Guidelines + FH Flashcards

1
Q

Who to screen regardless of risk factors (Based on sex and age)

A

Men and Women > 40

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What 15 patients to screen regardless of age and sex?

A
  • Established ASCVD
  • AAA
  • DM
  • Hypertension
  • Smoking
  • Stigmata of dyslipidemia
  • Premature ASCVD history in family hx
  • Family history of DSL
  • CKD < 60
  • Obesity > 30
  • Inflammatory diseases
  • HIV
  • ED
  • COPD
  • History of hypertensive pregnancy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

in IR patients, what are 5 other lipid modifiers to start statin therapy?

A
  • LDL > 3.5
  • APO B > 1.05
  • Non HDL > 4.2
  • Lp(a) > 50 mg/dl
  • Low HDL
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

In IR patients, what are the additional risk factors (Not risk modifier), to start lipid therapy in Men > 50 or Women > 60

A
  • IFG
  • High Waist Circumference
  • Smoker
  • Htn
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are 3 other risk modifiers for patients in IR category (covered Lipid ones, and risk factors)

A

HsCRP > 2

CAC > 0

History of premature CAD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are LDL, ApoB and Non-HDL thresholds to start statins in low risk patients

A
  • LDL > 5.0
  • Apo B > 1.45
  • Non HDL > 5.8
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are LDL, ApoB and Non HDL targets for primary prevention?

A

LDL < 2

ApoB < 0.8

-Non HDL < 2.6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What is the criteria for statin indicated condition with Diabetes?

A

Age > 40

Age > 30 and DM > 15 years duration

Microvascular disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is statin indicated condition for CKD?

A

-Age > 50 years and GFR < 60 or ACR > 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is LDL, ApoB and Non HDL targets in low risk patients who meet criteria for statin?

A
  • LDL < 2.5 or 50% reduction
  • ApoB < 0.85 g/l
  • Non HDL < 3.2 mmol/l
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is LDL, ApoB and Non HDL targets in IR risk patients who meet criteria for statin?

A

LDL < 2

ApoB < 0.8

Non HDL < 2.6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is LDL, ApoB and Non HDL targets in high risk patients who meet criteria for statin?

A

LDL < 1.8

Non HDL < 2.4

ApoB < 0.7

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

When should CAC scoring be used?

A

-In patients above 40 years old who are IR and need to make decision about treatment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Three patient population that CAC scoring should not be done?

A
  • Asymptomatic low risk patients
  • High risk
  • On statins
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

When can CAC score be considered in low risk individuals ?

A

over 40 years old with a family history of premature ASCVD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What subtypes of secondary prevention patients have been shown to derive the largest benefit from intensification of statin therapy?

A
  • Up to 1 year post ACS
  • Diabetes
  • Symptomatic PAD
  • More than 1 bed of vascular disease
  • Recurrent MI
  • MI in past 2 years
  • Previous CABG
  • LDL > 2.6 or Heterozygous FH
  • Lp(a) > 60 mg/dl
17
Q

What is the dose of Icosapent ethyl?

A

2000mg BID

18
Q

What are FH screening criteria? (2)

A

LDL > 5 mmol/l if more than 40 years old

LDL > 4.5 if 18-39 years old

LDL > 4 if less than 18

19
Q

What are the three major criteria for FH?

A
  • DNA Mutation
  • Tendon Xanthomas
  • LDL > 8.5
20
Q

What are the 2 minor criteria for FH?

A

FDR with elevated LDL

Proband or FDR with premature ASCVD

21
Q

Should patients with FH get genetic testing?

A

Yes, for cascade screening

22
Q

When should PCSK9 Inhibitors be used in patients with FH?

A

If they have not achieved a 50% reduction below LDL 3.5 mmol/l

23
Q

How should statins and Ezetimibe be managed in Pregnancy in Women with FH?

A

Statins and Ezetimibe should be stopped due to teratogenic risk

(And during Breastfeeding)

24
Q

What is the LDL target for those with FH?

A

-LDL < 50% and LDL < 2.5 (less than 2 if ASCVD)

25
Q

What do you need to do in Women that have pregnancy complications ? (GDM, HTN, Preeclampsia, Preterm birth, Stillbirth, Low birth weight infant, Placental abruption)

A

Lipid panel in the late postpartum period

26
Q

What to use in Women with pregnancy complications in place of 10 year calculators?

A

CV age